Three Quotes About an Unprecedented Year
When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.
Watch Online: CSL CEO at a White House Roundtable
Perreault made the case for a plasma-based hyperimmune to treat COVID-19.
CEO Paul Perreault at White House Roundtable
Perreault, representing the plasma industry, said an antibody treatment depends on additional donations from recovered patien…
CSL CEO: Don't Rush the COVID-19 Vaccine
Joining scientists and medical experts, Perreault urges rigor, precision and the necessary time to ensure vaccine safety.
Dealing With Challenges Head-On
CSL Limited CEO Paul Perreault offers a message of encouragement during the COVID-19 pandemic.
Podcast With CSL CEO Paul Perreault
“I want to make sure that we’re all supporting each other, practicing self-care, and if anybody reaches out, we’re there to t…
Four Academic Partnerships We're Excited About
Around the world, CSL is building creative partnerships with universities and research institutions.
CSL Limited Marks 25 Years on the ASX
Leaders ring the opening bell in Sydney and reflect on the company’s transformation into a global biotechnology business.
Behind the Scenes With Our CEO
It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.
Who’s Gettin’ In the Game in 2019?
Nominations are open for this year’s Junior National Championship.